Patents by Inventor Lawrence K. Olson

Lawrence K. Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF OBESITY, INSULIN RELATED DISEASES AND HYPERCHOLESTEROLEMIA
    Publication number: 20120283203
    Abstract: A process of enhancing insulin excretion in a subject includes administering to the subject a polyphenol active ingredient. The polyphenol active ingredient is a purified cyanidin-3-glycoside alone or purified cyanidin alone. The pharmaceutically acceptable carrier is administered with the polyphenol active ingredient.
    Type: Application
    Filed: April 30, 2012
    Publication date: November 8, 2012
    Applicant: Board of Trustees of Michigan State University
    Inventors: Muraleedharan G. Nair, Bolleddula Jayaprakasam, Lawrence K. Olson, Robert E. Schutzki
  • Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
    Patent number: 8198249
    Abstract: A process of enhancing insulin excretion in a subject includes administering to the subject a polyphenol active ingredient. The polyphenol active ingredient is a purified cyanidin-3-glycoside alone or purified cyanidin alone. The pharmaceutically acceptable carrier is administered with the polyphenol active ingredient.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: June 12, 2012
    Assignee: Board of Trustees of Michigan State University
    Inventors: Muraleedharan G. Nair, Bolleddula Jayaprakasam, Lawrence K. Olson, Robert E. Schutzki
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF OBESITY, INSULIN RELATED DISEASES AND HYPERCHOLESTEROLEMIA
    Publication number: 20110003762
    Abstract: A process of enhancing insulin excretion in a subject includes administering to the subject a polyphenol active ingredient. The polyphenol active ingredient is a purified cyanidin-3-glycoside alone or purified cyanidin alone. The pharmaceutically acceptable carrier is administered with the polyphenol active ingredient.
    Type: Application
    Filed: May 4, 2010
    Publication date: January 6, 2011
    Inventors: Muraleedharan G. Nair, Bolleddula Jayaprakasam, Lawrence K. Olson, Robert E. Schutzki
  • Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia
    Patent number: 7772195
    Abstract: A method for the treatment of obesity, diabetes, high cholesterol and related diseases including hyperglycemia, lipid disorders, hyperglyceridemia, dyslipidemia and atherosclerosis in mammals using anthocyanins, anthocyanidins, ursolic acid and/or betulinic acid is described. Compositions adapted for these treatments are also described.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: August 10, 2010
    Assignee: Board of Trustees of Michigan State University
    Inventors: Muraleedharan G. Nair, Bolleddula Jayaprakasam, Lawrence K. Olson, Robert E. Schutzki
  • Human pancreatic pluripotential stem cell line
    Publication number: 20030003088
    Abstract: A human pancreatic ductal epithelial cell line immortalized with the human papilloma virus E6 and E7 genes which has stem cell-like characteristics and which can be induced to differentiate into ductal-like cells and beta-like cells that produce insulin. The immortal cells or derivative thereof are useful for treating insulin-dependent diabetes and in assays for determining the ability of a chemical to induce pancreatic stem cell differentiation or malignancy.
    Type: Application
    Filed: April 30, 2002
    Publication date: January 2, 2003
    Applicant: Board of Trustees operating Michigan State University
    Inventors: Ming Sound Tsao, James E. Trosko, Burra V. Madhukar, Lawrence K. Olson, Loretta VanCamp